Galera Therapeutics, Inc: Piper Sandler initiates coverage with overweight rating; price target $42
GRTX•Related News
Gartner: Jefferies Raises Target Price to $190 From $140
IT•
Sasol sees FY2026 EPS at R17.50-R19.50, up 65%-84%
SSL•
Zebra Technologies <ZBRA.O>: TD Cowen raises target price to $450 from $400
ZBRA•
Booking Holdings Inc. <BKNG.O>: Jefferies Raises Target Price to $200 From $190
BKNG•
SpaceX: Piper Sandler cuts target price to $140 from $156
SPCX•